For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...

After a survey revealed all, a doctor has claimed men in the US are peeing all wrong and he explained why. Ever wondered if you urinate correctly? Well, a study conducted in 2023 looked into the way ...

Neurocrine Biosciences, Inc.’s NBIX share price has dipped by 18.53%, which has investors questioning if this is right time ...

(Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia (CAH) study of investigational atumelnant, a novel, once-daily oral ...

Q4 2024 Earnings Call Transcript February 6, 2025 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS ...

Learn how individualized screening and prevention strategies can help reduce breast cancer risk. Discover key risk factors, ...

First provided by Hackensack Meridian Hackensack University Medical Center last year, the Egg Harbor-based health care ...

Neurocrine Biosciences (($NBIX)) has held its Q4 earnings call. Read on for the main highlights of the call. Neurocrine Biosciences’ earnings call ...

One of the most prevalent cancers in males is prostate cancer, yet little is known about it. Results can be greatly enhanced ...

The following is a summary of “A cross-tissue transcriptome-wide association study identifies new susceptibility genes for benign prostatic hyperplasia,” published in the January 2025 issue of Urology ...